Found 318 matching trials
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients PHASE2 Maraviroc (MVC) is a type of HIV medicine called a CCR5 inhibitor. This stu...
Show More Location
UAB HIVTR-CCR5 Non-Network CRS
Learn More & Join Trial
Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants PHASE4 The primary purpose of this study is to evaluate the pulse wave velocity an...
Show More Status
Active Not Recruiting
Location
Hospital of the University of Pennsylvania
Learn More & Join Trial
Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus PHASE4 Following a transplant for hepatitis C cirrhosis, the infection comes back ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Allo HSCT Using RIC for Hematological Diseases PHASE2 This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance Renal Transplant Recipients PHASE4 The objective of the study is to compare the cardiovascular profile of an e...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis PHASE3 Prospective, randomized, parallel-group controlled, open-label, internation...
Show More Location
The University of Hong Kong
Learn More & Join Trial
Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention PHASE3 This randomized clinical trial studies standard GVHD prophylaxis with tacro...
Show More Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Learn More & Join Trial
Immunosuppression After Repeat Keratoplasty PHASE2 Purpose: To compare the efficacy of topical 0.03% tacrolimus with systemic ...
Show More Location
Ophthalmic Research Center
Learn More & Join Trial
Conversion Pharmacodynamic Study in Stable Renal Transplant Patients Receiving Tacrolimus Two Times a Day to a New Formulation of Tacrolimus - LCP Tacro - 1 Time a Day. PHASE4 LCP-Tacro is an extended-release formulation of tacrolimus designed for onc...
Show More Location
Nephrology Department- Hospital Universitari Bellvtge
Learn More & Join Trial
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant PHASE2 The researchers are doing this study to compare 2 different GVHD prevention...
Show More Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial